SEC Form 4 · accession 0001209191-15-033805
Eledon Pharmaceuticals, Inc. · ELDN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cheryl Cohen
Director
Period of report
Apr 9, 2015
Accepted (ET)
Apr 13, 2015 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001404281
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.08 | Apr 9, 2015 | A | 25,000 | A | — | Apr 8, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1This option vests with respect to 1/3rd of the shares underlying the option on April 09, 2016 and an additional 1/12th quarterly thereafter through April 09, 2018.